Baxter International Inc. (BAX) News
Baxter International Inc. (BAX)
Today's Latest Price: $75.77 USD
Updated Nov 23 4:00pm
Add BAX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
Filter BAX News Items
BAX News Results
| Event/Time | Symbol | Company | News Detail | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest BAX News From Around the Web
Below are the latest news stories about Baxter International Inc that investors may wish to consider to help them evaluate BAX as an investment opportunity.
Catheter Securement Devices Market Insights, Forecast to 2027 | 3M Company, C.R. Bard, Baxter International, Convatec Inc, etc.Industry Overview of Catheter Securement Devices Market Report 2020 The global catheter securement devices market is forecast to reach USD 1.74 Billion by 2027, according to a new report by Reports and Data. Catheter Securement Devices can be defined as medical |
Acute Wound Care Market With Leading Players like Molnlycke Health Care AB, Smith & Nephew plc., Acelity L.P. Inc., ConvaTec Group Plc., 3M, Ethicon, Medtronic, Coloplast A/S, Hollister Incorporated, Baxter International Inc.Acute wounds affect millions of people each day worldwide. In the recent decades, clinicians have gained a better understanding of the mechanisms underlying wound repair and healing. Acute wound care management involves number of products that are used by physicians |
Peritoneal Dialysis Market - Global Outlook & Forecast Report 2020-2025 Featuring Baxter International, Fresenius Medical Care, Medionics, MedtronicDUBLIN, Sept. 28, 2020 /PRNewswire/ -- The "Peritoneal Dialysis Market - Global Outlook & Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The peritoneal dialysis market by revenue is expected to grow at a CAGR of over 6% during the period 2019-2025 Market… |
United States Medical Syringes Procurement Research Report 2020 Featuring Cardinal Health, Becton, Dickinson and Co, 3M Company, Fresenius Group & Baxter International - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "Medical Syringes in the US - Procurement Research Report" has been added to ResearchAndMarkets.com's offering. This report is intended to assist buyers of disposable syringes used for medical purposes There are different types of medical syringes, including hypodermic syringes, medical bulb syringes, blood collection syringes and fountain syringes. This report includes prefilled syringes, which are disposable syringes prefilled with unit dose medication. Although t |
Baxter Announces Exclusive Distribution Agreement With bioMérieux for Novel Acute Kidney Injury Diagnostic Test in Europe and U.S.DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced a distribution agreement with bioMérieux (EPA:BIM), a global leader in in vitro diagnostics, for the NEPHROCLEARTM CCL14 diagnostic test. The NEPHROCLEARTM CCL14 test is currently in development for use in assessing the risk of developing persistent severe acute kidney injury (AKI). The agreement is part of a previously announced collaboration between Baxter and bioMérieux to i |
Global Pre-Filled Syringes Market: COVID-19 Business Continuity Plan | Evolving Opportunities with Baxter International Inc. and Becton, Dickinson and Co. | TechnavioLONDON--(BUSINESS WIRE)-- #GlobalPrefilledSyringesMarket--The Global Pre-filled Syringes Market will grow by $ 4.23 bn during 2020-2024 |
IPO Update: Outset Medical Finalizes Terms For IPOQuick Take Outset Medical (OM) has filed to raise $175 million from the sale of its common stock in an IPO, according to an amended registration statement. The company has developed an improved kidney dialysis device for institutional and home use. OM is growing quickly from a low base but... |
Baxter Is Largely Defensive: Hide In Baxter, But Don't SpeculateOverview Baxter Healthcare (BAX) is an excellent defensive stock. Its business model, revenue streams, and historical stock performance lend weight to its standing as a bulwark of stability and possibly mild gains in the healthcare/pharmaceutical sector. As you can see, the company held its own fairly well in the last... |
Analysis on Impact of COVID-19- Global Von Willebrand Disease Therapeutics Market 2020-2024 | Evolving Opportunities with Apotex Inc. and Baxter International Inc. | TechnavioLONDON--(BUSINESS WIRE)-- #GlobalVonWillebrandDiseaseTherapeuticsMarket--The Global Von Willebrand Disease Therapeutics Market will grow by $ 165.48 mn during 2020-2024 |
P/E Ratio Insights for Baxter InternationalRight now, Baxter International Inc. (NYSE: BAX) share price is at $81.97, after a 1.87% decrease. Over the past month, the stock … |
